Experts pick their favorite long-term investments in medical diagnostics, testing and laboratory services.
Let's take a close look at BIIB and arrive at a strategy for the shares.
The smallish clinical-stage vaccine company looks like a trade, not an investment, and might be approached as an option play.
Markets are clearly different now. I did not grow up, nor was I trained for this environment. Nobody else you hear today was either.
Let's review the charts and indicators.
The extent of the measures taken to combat the virus seem to be an overreaction, and no one should count on a vaccine being a magic bullet.
The drugmaker is a buying opportunity right now.
The biopharmaceutical company shows bullish charts that signal a breakout to new all-time highs. The charts and indicators are bullish,
BioDelivery Sciences International and Tivity Health are two candidates investors should consider going forward.
Now that REGN has clearly broken out above the highs of 2015 there is no chart resistance.